Related Experiment Video
Updated: Jun 10, 2026

Visualizing and Quantifying Endonuclease-Based Site-Specific DNA Damage
Published on: August 21, 2021
Lynch syndrome-associated mutations in MSH2 alter DNA repair and checkpoint response functions in vivo
Adam S Mastrocola1, Christopher D Heinen
1Neag Comprehensive Cancer Center and Center for Molecular Medicine, University of Connecticut Health Center, Farmington, Connecticut 06030-3101, USA.
Abstract:
The DNA mismatch repair (MMR) pathway is essential in maintaining genomic stability through its role in DNA repair and the checkpoint response. Loss of DNA MMR underlies the hereditary cancer disease Lynch Syndrome (LS). Germline mutations in MSH2 account for approximately 40% of LS patients and of these, 18% are missense variants. One important clinical challenge has been discriminating between missense variants that are pathogenic and those that are not. Current analysis of missense mutations in MSH2 is performed using a combination of clinical, biochemical, and functional data; however, suitable cell culture models to test the various functions of the DNA MMR proteins are lacking. Here, we have generated human cell lines stably expressing a subset of MSH2 missense mutants and tested their effect on DNA repair and checkpoint response functions. We have expanded on previous biochemical and functional analyses performed in non-human systems to further understand defects conferred by this subset of single amino acid alterations. The functional characterization of MSH2 missense mutants combined with clinical and biochemical data is essential for appropriate patient management and genetic counseling decisions.
Insights
Researchers developed new human cell models to assess DNA mismatch repair (MMR) gene MSH2 missense mutations. This aids in distinguishing pathogenic variants, crucial for Lynch Syndrome diagnosis and patient care.
Area of Science:
- Genetics and Genomics
- Molecular Biology
- Cancer Research
Background:
- The DNA mismatch repair (MMR) pathway is critical for genomic stability and preventing cancer.
- Loss of MMR function causes Lynch Syndrome (LS), a hereditary cancer predisposition.
- MSH2 gene mutations are found in ~40% of LS patients, with 18% being missense variants.
Purpose of the Study:
- To develop and utilize human cell models for functional analysis of MSH2 missense variants.
- To improve the discrimination between pathogenic and benign MSH2 missense mutations.
- To provide better tools for genetic counseling and patient management in Lynch Syndrome.
Main Methods:
- Generated human cell lines stably expressing specific MSH2 missense mutants.
- Assessed the impact of these mutants on DNA repair functions.
- Evaluated the effect of mutants on DNA damage checkpoint response.
Main Results:
- Demonstrated functional consequences of specific MSH2 missense alterations in human cells.
- Provided a platform for expanded biochemical and functional analyses.
- Expanded understanding of defects caused by single amino acid changes in MSH2.
Conclusions:
- Functional characterization of MSH2 missense mutants in human cell models is essential.
- Integrating functional data with clinical and biochemical information aids patient management.
- Improved methods for variant classification are vital for Lynch Syndrome genetic counseling.
Related Concept Videos
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Mismatch Repair
Mismatch Repair
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair
Nucleotide Excision Repair
